Pulike Biological Engineering, Inc.
public_traded
Pulike Biological Engineering, Inc. is publicly traded on SHH under ticker 603566.SS.
Pulike Biological Engineering, Inc. engages in the research and development, production, and marketing of veterinary biological products and drugs. It offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. The company is headquartered in Luoyang, China.